Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Ruxrungtham

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
HIV Medicine|October 20, 2007
Efficacy and tolerability of a double boosted protease inhibitor (lopinavir + saquinavir/ritonavir) regimen in HIV-infected patients who failed treatment with nonnucleoside reverse transcriptase inhibitorsP Chetchotisakd, S Anunnatsiri, P Mootsikapun, et al.
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet|January 22, 2002
Intrapartum and neonatal zidovudine treatment in reduction of perinatal HIV-1 transmission in BangkokP Thaithumyanon, U Thisyakorn, S Limpongsanurak, et al.
Magnetic Resonance Imaging|October 12, 2000
Magnetic resonance spectroscopy of the brain in neurologically asymptomatic HIV-infected patientsN Suwanwelaa, P Phanuphak, K Phanthumchinda, et al.
HIV Medicine|November 5, 2005
Indinavir/ritonavir 800/100 mg bid and efavirenz 600 mg qd in patients failing treatment with combination nucleoside reverse transcriptase inhibitors: 96-week outcomes of HIV-NAT 009M A Boyd, U Siangphoe, K Ruxrungtham, et al.
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet|September 19, 2001
Intrapartum zidovudine infusion alone failed to reduce both maternal HIV-1 viral load and HIV-1 infection in infantS Limpongsanurak, P Thaithumyanon, U Thisyakorn, et al.
International Journal of STD & AIDS|May 15, 2012
Assessing adherence in Thai patients taking combination antiretroviral therapyS J Kerr, A Avihingsanon, O Putcharoen, et al.
HIV Medicine|July 31, 2007
Ferritin levels during structured treatment interruption of highly active antiretroviral therapyJ Boom, E Kösters, C Duncombe, et al.
The Journal of Antimicrobial Chemotherapy|August 27, 2004
Pharmacokinetic study of saquinavir hard gel caps/ritonavir in HIV-1-infected patients: 1600/100 mg once-daily compared with 2000/100 mg once-daily and 1000/100 mg twice-dailyR S Autar, J Ananworanich, W Apateerapong, et al.
Allergy|June 25, 2016
High-dose bee venom exposure induces similar tolerogenic B-cell responses in allergic patients and healthy beekeepersT Boonpiyathad, N Meyer, M Moniuszko, et al.
Australian and New Zealand Journal of Medicine|May 9, 2000
A comparison of two dosing regimens of zidovudine in Thai adults with early symptomatic HIV infection. Conducting clinical HIV trials in South-East AsiaP Phanuphak, M L Grayson, S Sirivichayakul, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
HIV Medicine|October 20, 2007
Efficacy and tolerability of a double boosted protease inhibitor (lopinavir + saquinavir/ritonavir) regimen in HIV-infected patients who failed treatment with nonnucleoside reverse transcriptase inhibitorsP Chetchotisakd, S Anunnatsiri, P Mootsikapun, et al.
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet|January 22, 2002
Intrapartum and neonatal zidovudine treatment in reduction of perinatal HIV-1 transmission in BangkokP Thaithumyanon, U Thisyakorn, S Limpongsanurak, et al.
Magnetic Resonance Imaging|October 12, 2000
Magnetic resonance spectroscopy of the brain in neurologically asymptomatic HIV-infected patientsN Suwanwelaa, P Phanuphak, K Phanthumchinda, et al.
HIV Medicine|November 5, 2005
Indinavir/ritonavir 800/100 mg bid and efavirenz 600 mg qd in patients failing treatment with combination nucleoside reverse transcriptase inhibitors: 96-week outcomes of HIV-NAT 009M A Boyd, U Siangphoe, K Ruxrungtham, et al.
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet|September 19, 2001
Intrapartum zidovudine infusion alone failed to reduce both maternal HIV-1 viral load and HIV-1 infection in infantS Limpongsanurak, P Thaithumyanon, U Thisyakorn, et al.
International Journal of STD & AIDS|May 15, 2012
Assessing adherence in Thai patients taking combination antiretroviral therapyS J Kerr, A Avihingsanon, O Putcharoen, et al.
HIV Medicine|July 31, 2007
Ferritin levels during structured treatment interruption of highly active antiretroviral therapyJ Boom, E Kösters, C Duncombe, et al.
The Journal of Antimicrobial Chemotherapy|August 27, 2004
Pharmacokinetic study of saquinavir hard gel caps/ritonavir in HIV-1-infected patients: 1600/100 mg once-daily compared with 2000/100 mg once-daily and 1000/100 mg twice-dailyR S Autar, J Ananworanich, W Apateerapong, et al.
Allergy|June 25, 2016
High-dose bee venom exposure induces similar tolerogenic B-cell responses in allergic patients and healthy beekeepersT Boonpiyathad, N Meyer, M Moniuszko, et al.
Australian and New Zealand Journal of Medicine|May 9, 2000
A comparison of two dosing regimens of zidovudine in Thai adults with early symptomatic HIV infection. Conducting clinical HIV trials in South-East AsiaP Phanuphak, M L Grayson, S Sirivichayakul, et al.
Pageof 5